Search for: "MERCK/SCHERING-PLOUGH PHARMACEUTICALS" Results 1 - 20 of 72
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Mar 2009, 10:48 pm
The tie-up will double the number of potential drugs Merck has in Phase III development to 18.Merck is headquartered at Whitehouse Station in NJ, and Schering-Plough is in nearby Union County. [read post]
16 Dec 2009, 2:51 pm by Sheppard Mullin
 Schering-Plough and Merck are each engaged in the research, development, manufacture, distribution and sale of human pharmaceutical and animal health products. [read post]
22 Jul 2009, 12:32 pm
In fact, a 2007 piece in the New York Times suggested that Merck and Schering-Plough may have also suppressed evidence from clinical trials that found a connection between the drugs and liver problems. [read post]
15 Feb 2013, 2:05 pm by Lyle Roberts
The case is actually two cases - against Merck and Schering-Plough Corp.... [read post]
15 Oct 2008, 11:55 am
Ed Silverman at Pharmalot reports that the City of New Haven is seeking outside counsel to sue Merck and Schering-Plough for "allegedly defective/ineffective pharmaceuticals Vytorin and Zetia," two cholesterol lowering drugs. [read post]
25 Feb 2014, 2:49 pm
Its former U.S. affiliate became then the company Schering-Plough. [read post]
8 Dec 2008, 12:17 pm
Recent layoffs reported in the drug industry include Sanofi (650 sales reps);Novartis (550 U.S. salespersons);Merck (8,000); Wyeth (2,440); GSK (1,000); Schering-Plough (5,500);and Boehringer Ingelheim (200). [read post]
20 Mar 2009, 2:20 am
The column returns to honor two lawyers behind two of the biggest, and most significant, transactions so far this year--Cooley Godward's Richard Climan advised Gilead Sciences on its $1.4 billion acquisition of CV Therapeutics, while Fried Frank's David Shine represented Merck in its $41 billion merger with Schering-Plough. [read post]
29 May 2014, 1:40 pm by RatnerPrestia
He has handled complex pharmaceutical and biotech patent cases throughout his career, most recently specializing in global patent litigation and IP licensing at Merck and Schering-Plough. [read post]
17 Jun 2009, 7:59 am
Here’s how it breaks down according to the filing: JP Morgan will collect $45 million from Merck; Goldman will get up to $33.3 million from Schering-Plough and Morgan Stanley, which acted as an additional financial advisor to Schering-Plough and provided the all-important “synergies valuation” will collect $22 million. [read post]
18 Dec 2013, 2:13 pm by Tom Lamb
The plaintiffs contend that Organon and Schering-Plough, among other things, failed to adequately design and manufacture NuvaRing and failed to adequately warn of the alleged increased risk of venous thromboembolism (“VTE”) posed by NuvaRing, and/or downplayed the risk of VTE. [read post]
22 Apr 2011, 10:51 am by Zoe Tillman
Merck merged with Schering-Plough Corp. on Nov. 3, 2009, and, according to the complaint, had told PETA that they needed to prove ownership in Schering-Plough to be eligible. [read post]
20 Aug 2010, 12:56 pm by Stephen Albainy-Jenei
Significant Case Studies Give You The Chance To Learn About New Partnerships and New Agreements In The Industry * BMS and Allergan * Merck and Schering-Plough * Sanofi-Aventis and Intelliject * J&J and Takeda * Eli Lilly and Kowa Pharmaceuticals * Eli Lilly and Incyte Corporation The Perfect Pitch: Biotech Investment Challenge In this groundbreaking session, Biotech companies will have the chance to present your new research and new therapies (either in early… [read post]
28 Dec 2009, 7:57 am by Green and Associates
Schering-Plough recently merged with Merck, and is now known as Merck & Co.California's $21.3 million agreement is one of three settlements negotiated with Schering-Plough, collectively totaling $69 million, over falsely inflated drug prices. [read post]
11 Nov 2008, 5:37 pm
Vytorin is made by the drug companies Merck and Schering-Plough Pharmaceuticals. [read post]
3 Nov 2021, 9:52 am by Tim De Chant
Yesterday, the court heard that Holmes did it once more, sending reports that prominently featured the logo of Schering-Plough, the large pharmaceutical company that was acquired by Merck in 2009. [read post]